Capvizr

Moa Technology Secures $22.2 Million in Latest Series C Funding Round

Capvizr Staff · · 2 min read

Moa Technology secured $22.2 million in its latest Series C, adding another data point to the Healthcare & Life Sciences funding market.

Series C$22.2 millionHealthcare & Life SciencesUndisclosed HQ

Moa Technology Raises $22.2 million in Funding

Moa Technology raises Series C round co-led by Oxford Science Enterprises and Supernova Invest Agricultural biotech firm Moa Technology raises £22.2m - UKTN British biotech Moa Technology raises $29M Series C to combat herbicide.

Investors Behind the Funding

The round was backed by Oxford Science Enterprises. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Moa Technology operates in Healthcare & Life Sciences. Moa Technology's financing adds to recent private-market activity.

Strategic Use of Funds

combat herbicide-

Looking Ahead

Moa Technology raises Series C round co-led by Oxford Science Enterprises and Supernova Invest

Source reference: original announcement/article.

View Moa Technology's full profile and funding history on Capvizr →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime